Erratum: Noninvasive in vivo monitoring of tissue-specific global gene expression in humans (Proceedings of the National Academy of Sciences of the United States of America (2014) 111 (7361-7366) DOI: 10.1073/pnas.1405528111);Noninvasive in vivo monitoring of tissue-specific global gene expression in humans

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7361-7366

  Koh, Winston ^a   Pan, Wenying ^a   Gawad, Charles ^a   Christina Fan, H ^a   Kerchner, Geoffrey A ^b   Wyss Coray, Tony ^b   Blumenfeld, Yair J ^c   El Sayed, Yasser Y ^c   Quake, Stephen R ^a  

^a Stanford University   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; TRANSCRIPTOME;

ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LONGITUDINAL STUDY; MATERNAL BLOOD; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREGNANT WOMAN; PRIORITY JOURNAL; RNA ANALYSIS;

CELL-FREE NUCLEIC ACIDS; GENOMICS; NONINVASIVE DIAGNOSTICS;

ADULT; ALZHEIMER DISEASE; APOPTOSIS; BRAIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; RNA; TIME FACTORS; TRANSCRIPTOME;

EID: 84901049709     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1412162111     Document Type: Erratum

References (62)

1. Mandel P, Mtais P (1948) Les acides nucliques du plasma sanguin chez lhomme. C R Acad Sci Paris 142:241-243.
2. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105(42):16266-16271.
3. Fan HC, et al. (2012) Non-invasive prenatal measurement of the fetal genome. Nature 487(7407):320-324.
4. Snyder TM, Khush KK, Valantine HA, Quake SR (2011) Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci USA 108(15):6229-6234.
5. Dressman D, Yan H, Traverso G, Kinzler KW, Vogelstein B (2003) Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc Natl Acad Sci USA 100(15):8817-8822.
6. Diehl F, et al. (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9): 985-990.
7. Leary RJ, et al. (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4(162):ra154.
8. Bianchi DW, et al. (2014) In case you missed it: The Prenatal Diagnosis section editors bring you the most significant advances of 2013. Prenat Diagn 34(1):1-5.
9. Kopreski MS, Benko FA, Kwak LW, Gocke CD (1999) Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 5(8): 1961-1965.
10. Lo K-W, et al. (1999) Analysis of cell-free Epstein-Barr virus associated RNA in the plasma of patients with nasopharyngeal carcinoma. Clin Chem 45(8 Pt 1):1292-1294.
11. Chen XQ, et al. (2000) Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res 6(10):3823-3826.
12. Garca-Olmo D, Garca-Olmo DC, Ontan J, Martinez E, Vallejo M (1999) Tumor DNA circulating in the plasma might play a role in metastasis. The hypothesis of the genometastasis. Histol Histopathol 14(4):1159-1164.
13. Poon LLM, Leung TN, Lau TK, Lo YMD (2000) Presence of fetal RNA in maternal plasma. Clin Chem 46(11):1832-1834.
14. Tsui NBY, Ng EKO, Lo YMD (2002) Stability of endogenous and added RNA in blood specimens, serum, and plasma. Clin Chem 48(10):1647-1653.
15. Hasselmann DO, Rappl G, Tilgen W, Reinhold U (2001) Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 47(8):1488-1489.
16. Ng EKO, et al. (2003) mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 100(8):4748-4753.
17. Lo YMD, et al. (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13(2):218-223.
18. Ng EKO, et al. (2003) The concentration of circulating corticotropin-releasing hormone mRNA in maternal plasma is increased in preeclampsia. Clin Chem 49(5): 727-731.
19. Maron JL, et al. (2007) Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood. J Clin Invest 117(10):3007-3019.
20. Trapnell C, et al. (2013) Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31(1):46-53.
21. Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO (2012) Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE 7(2):e30733.
22. Memczak S, et al. (2013) Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495(7441):333-338.
23. Jeck WR, et al. (2013) Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19(2):141-157.
24. Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44-57.
25. Licht P, Russu V, Wildt L (2001) On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: Implications for differentiation and implantation. Semin Reprod Med 19(1):37-47.
26. Krege S, et al. (2008) European consensus conference on diagnosis and treatment of germ cell cancer: A report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I. Eur Urol 53(3):478-496.
27. HOgh AM, et al. (2001) zeta-, epsilon-, and gamma-Globin mRNA in blood samples and CD71(+) cell fractions from fetuses and from pregnant and nonpregnant women, with special attention to identification of fetal erythroblasts. Clin Chem 47(4): 645-653.
28. Than NG, et al. (2008) Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome. Virchows Arch 453(4): 387-400.
29. Kveiborg M, Albrechtsen R, Couchman JR, Wewer UM (2008) Cellular roles of ADAM12 in health and disease. Int J Biochem Cell Biol 40(9):1685-1702.
30. Laigaard J, et al. (2005) The level of ADAM12-S in maternal serum is an early firsttrimester marker of fetal trisomy 18. Prenat Diagn 25(1):45-46.
31. Ito N, et al. (2004) ADAMs, a disintegrin and metalloproteinases, mediate shedding of oxytocinase. Biochem Biophys Res Commun 314(4):1008-1013.
32. Fishman L, Miyayama H, Driscoll SG, Fishman WH (1976) Developmental phase-specific alkaline phosphatase isoenzymes of human placenta and their occurrence in human cancer. Cancer Res 36(7 PT 1):2268-2273.
33. Okamoto T, et al. (1990) Expression of human placenta alkaline phosphatase in placenta during pregnancy. Placenta 11(4):319-327.
34. Leitner K, et al. (2001) Placental alkaline phosphatase expression at the apical and basal plasma membrane in term villous trophoblasts. J Histochem Cytochem 49(9): 1155-1164.
35. Fishman WH, Ghosh NK, Inglis NR, Green S (1968) Quantitation of the placental isoenzyme of alkaline phosphatase in pregnancy sera. Enzymologia 34(5):317-321.
36. Meyer RE, Thompson SJ, Addy CL, Garrison CZ, Best RG (1995) Maternal serum placental alkaline phosphatase level and risk for preterm delivery. Am J Obstet Gynecol 173(1):181-186.
37. Moawad AH, et al.; NICHD MFMU Network (2002) The Preterm Prediction Study: The value of serum alkaline phosphatase, alpha-fetoprotein, plasma corticotropinreleasing hormone, and other serum markers for the prediction of spontaneous preterm birth. Am J Obstet Gynecol 186(5):990-996.
38. Barbiero L, et al. (2003) BACE-2 is overexpressed in Downs syndrome. Exp Neurol 182(2):335-345.
39. Page NM, Dakour J, Morrish DW (2006) Gene regulation of neurokinin B and its receptor NK3 in late pregnancy and pre-eclampsia. Mol Hum Reprod 12(7):427-433.
40. Schlembach D, et al. (2003) Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women. Am J Obstet Gynecol 189(5):1418-1422.
41. Jackman SM, Kong X, Fant ME (2012) Plac1 (placenta-specific 1) is essential for normal placental and embryonic development. Mol Reprod Dev 79(8):564-572.
42. Purwosunu Y, et al. (2007) Cell-free mRNA concentrations of CRH, PLAC1, and selectin-P are increased in the plasma of pregnant women with preeclampsia. Prenat Diagn 27(8):772-777.
43. Ruoslahti E, Pihko H, Seppl M (1974) Alpha-fetoprotein: Immunochemical purification and chemical properties. Expression in normal state and in malignant and nonmalignant liver disease. Transplant Rev 20(0):38-60.
44. Rosen T, DAlton ME (2005) Down syndrome screening in the first and second trimesters: What do the data show? Semin Perinatol 29(6):367-375.
45. Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH (2012) First-trimester screening for neural tube defects using alpha-fetoprotein. Fetal Diagn Ther 31(2):109-114.
46. Li R, Thorens B, Loeken MR (2007) Expression of the gene encoding the high-Km glucose transporter 2 by the early postimplantation mouse embryo is essential for neural tube defects associated with diabetic embryopathy. Diabetologia 50(3): 682-689.
47. Moley KH, Chi MM, Knudson CM, Korsmeyer SJ, Mueckler MM (1998) Hyperglycemia induces apoptosis in pre-implantation embryos through cell death effector pathways. Nat Med 4(12):1421-1424.
48. Santer R, et al. (1997) Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet 17(3):324-326.
49. Hui L, Slonim DK, Wick HC, Johnson KL, Bianchi DW (2012) The amniotic fluid transcriptome: A source of novel information about human fetal development. Obstet Gynecol 119(1):111-118.
50. Xiang C, et al. (2012) RP58/ZNF238 directly modulates proneurogenic gene levels and is required for neuronal differentiation and brain expansion. Cell Death Differ 19(4): 692-702.
51. Hanashima C, Li SC, Shen L, Lai E, Fishell G (2004) Foxg1 suppresses early cortical cell fate. Science 303(5654):56-59.
52. Ariani F, et al. (2008) FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 83(1):89-93.
53. Fry M, Ferguson AV (2007) The sensory circumventricular organs: Brain targets for circulating signals controlling ingestive behavior. Physiol Behav 91(4):413-423.
54. Matsui T, et al. (2007) Expression of APP pathway mRNAs and proteins in Alzheimers disease. Brain Res 1161:116-123.
55. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimers disease. Neuroreport 5(18):2529-2533.
56. Estus S, et al. (1997) Aggregated amyloid-beta protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction. J Neurosci 17(20): 7736-7745.
57. Imaizumi K, et al. (1999) The cell death-promoting gene DP5, which interacts with the BCL2 family, is induced during neuronal apoptosis following exposure to amyloid beta protein. J Biol Chem 274(12):7975-7981.
58. Mattson MP (2000) Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 1(2):120-129.
59. Nagase T, et al. (1999) Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 6(1):63-70.
60. Nakajima D, et al. (2002) Construction of expression-ready cDNA clones for KIAA genes: Manual curation of 330 KIAA cDNA clones. DNA Res 9(3):99-106.
61. Spurgeon SL, Jones RC, Ramakrishnan R (2008) High throughput gene expression measurement with real time PCR in a microfluidic dynamic array. PLoS ONE 3(2): e1662.
62. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3(6):1101-1108.